How Could a New Longevity Medicine Create $200B Per Year in Revenue? Dr. Greg Bailey and I asked top VC Alex Colville from age1
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
How non-experts can invest in biotech
Alex advises LPs to invest via experienced VC funds, emphasizing typical venture timelines and that longevity timelines match standard venture horizons.
Play episode from 13:30
Transcript
